-
diabetes drug
Rezulin for FDA
review on July 31, 1996. The
medical officer ****igned to the review, Dr. John L. Gueriguian,
cited Rezulin's potential to...
-
January 1999. Its
subsidiary Parke-Davis
marketed the
antidiabetic drug
Rezulin,
which was
approved by the FDA in
January 1997 but
withdrawn by them in...
-
examples include cerivastatin (brand
names Baycol and Lipobay),
troglitazone (
Rezulin) and
rofecoxib (Vioxx).
Further examples include the
swine flu vaccine...
-
Ciglitazone Darglitazone Englitazone Netoglitazone Rivoglitazone Troglitazone (
Rezulin),
withdrawn due to
increased incidence of drug-induced hepatitis. Balaglitazone...
-
removing from the U.S.
market the
unsafe drugs Omniflox an antibiotic,
Rezulin, a
diabetes treatment, Fen-Phen and Redux, weight-loss drugs, and phenylpropanolamine...
-
Glaxo Wellcome, Parke-Davis
developed and
marketed the anti-diabetic drug
Rezulin (troglitazone) in the late 1990s. The drug was
withdrawn in 2000 because...
-
examples include cerivastatin (brand
names Baycol and Lipobay),
troglitazone (
Rezulin) and
rofecoxib (Vioxx).[citation needed] The
entire process of developing...
-
Triparanol 1962 France, US Cataracts, alopecia, ichthyosis.
Troglitazone (
Rezulin) 2000 US,
Germany Hepatotoxicity Trovafloxacin (Trovan) 1999–2001 European...
-
sodium (INN)
Revitropin revizinone (INN)
revospirone (INN)
Rexomun Reyataz rezafungin (INN)
rezatomidine (USAN, INN)
Rezdiffra Rezipas Rezulin Rezzayo...
-
gabapentin (Neurontin,
epilepsy and
neuropathic pain),
troglitazone (
Rezulin, diabetes), and
atorvastatin (Lipitor,
cholesterol lowering). In 1987 Pedro...
